SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-211193
Filing Date
2014-05-23
Accepted
2014-05-23 13:03:55
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d723121d10q.htm 10-Q 177899
2 EX-31.1 d723121dex311.htm EX-31.1 9076
3 EX-31.2 d723121dex312.htm EX-31.2 9165
4 EX-32.1 d723121dex321.htm EX-32.1 2824
5 EX-32.2 d723121dex322.htm EX-32.2 2959
  Complete submission text file 0001193125-14-211193.txt   2227384

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alse-20140331.xml EX-101.INS 214735
7 XBRL TAXONOMY EXTENSION SCHEMA alse-20140331.xsd EX-101.SCH 32002
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alse-20140331_cal.xml EX-101.CAL 39635
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alse-20140331_def.xml EX-101.DEF 83827
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alse-20140331_lab.xml EX-101.LAB 256744
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alse-20140331_pre.xml EX-101.PRE 165904
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 14866409
SIC: 2834 Pharmaceutical Preparations